Related Experiment Video
Updated: Dec 22, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Cardiac surgery in patients with Hemophilia:is it safe?
Amjad Shalabi1,2,3,4, Erez Kachel5,6,7, Alexander Kogan5
1Chaim Sheba Medical Center, Tel-Hashomer, 52621, Ramat-Gan, Israel. amjadra3008@gmail.com.
Insights
Major cardiac surgery is safe for hemophilia patients with careful management. This study highlights the need for a multidisciplinary team and close monitoring for successful outcomes in hemophilia patients undergoing cardiovascular procedures.
Area of Science:
- Cardiology
- Hematology
Background:
- Increased life expectancy in hemophiliacs leads to higher rates of age-related cardiovascular diseases.
- Hemophilia patients now face similar cardiovascular disease burdens as the general population.
- This study examines cardiac surgery outcomes in hemophiliacs.
Purpose of the Study:
- To evaluate the safety and outcomes of cardiac surgery in patients with hemophilia.
- To describe the peri-operative management and complications in this patient cohort.
Main Methods:
- Retrospective review of hemophilia patients who underwent cardiac surgery between 2004 and 2019.
- Data collected included patient demographics, hemophilia type, surgical procedures, and peri-operative management.
Main Results:
- Ten patients with hemophilia A, B, or C (factor XI deficiency) underwent cardiac surgery.
- Procedures included coronary artery bypass grafts and aortic valve replacement.
- Management involved factor substitution or fresh frozen plasma; one mortality and one bleeding complication occurred.
Conclusions:
- Major cardiac surgery can be safely performed in patients with hemophilia.
- A multidisciplinary team approach is crucial for successful outcomes.
- Strict postoperative monitoring is essential for managing complications.
Background:
The life expectancy of hemophiliacs is similar to that of the general population. As a result, the prevalence of age-related cardiovascular diseases has increased. We present our experience with hemophilia patients who underwent cardiac surgery in our Medical Center between 2004 and 2019.
Methods:
All hemophilia patients who underwent cardiac surgery were identified, and their peri-operative data evaluated retrospectively.
Results:
Ten patients were identified: six with hemophilia-A, one with hemophilia-B, and three with hemophilia-C (factor XI deficiency). Cardiac procedures included ten coronary artery bypass grafts and one aortic valve replacement. Hemophilia-A and B patients were treated with factor substitution, whereas patients with factor XI deficiency were treated with fresh frozen plasma. One patient died, and one patient suffered from non-active gastrointestinal bleeding.
Conclusions:
While major cardiac surgery can be performed safely on patients with hemophilia, a multidisciplinary team approach and strict postoperative monitoring are essential in order to achieve optimal results.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

